Latest Schemes Of Arrangement News

Page 33 of 60
Washington H. Soul Pattinson and Brickworks Limited are advancing their proposed merger with key shareholder meetings and Supreme Court hearings scheduled in September 2025.
Victor Sage
Victor Sage
2 Sept 2025
Dundee Precious Metals has received court sanction for its recommended acquisition of Adriatic Metals, paving the way for a scheme of arrangement expected to take effect on 3 September 2025. The transaction will result in Adriatic shares being cancelled and DPM’s listing on the ASX as a foreign exempt entity.
Maxwell Dee
Maxwell Dee
1 Sept 2025
Warriedar Resources has secured a crucial ASX waiver allowing the cancellation of 5 million unlisted options without shareholder approval, smoothing the path for Capricorn Metals’ acquisition scheme.
Maxwell Dee
Maxwell Dee
1 Sept 2025
MAC Copper Limited shareholders have decisively approved the proposed acquisition by Harmony Gold, clearing a major hurdle for the transaction. The scheme now awaits final court sanction before becoming effective.
Maxwell Dee
Maxwell Dee
1 Sept 2025
Astron Limited has finalized its move from Hong Kong to Australia, issuing new securities on a two-for-one basis and preparing for ASX trading starting September 1, 2025.
Maxwell Dee
Maxwell Dee
29 Aug 2025
MAC Copper Limited shareholders convened pivotal meetings to vote on Harmony Gold's proposed acquisition, valuing MAC at over US$1 billion with a 20.7% premium. The outcome will reshape MAC's ownership and market presence.
Maxwell Dee
Maxwell Dee
29 Aug 2025
Mad Paws Holdings has completed the divestment of its Pet Chemist business and announced the resignation of Executive Director Howard Humphreys, advancing its proposed acquisition by Rover Group.
Victor Sage
Victor Sage
29 Aug 2025
Mayne Pharma Group Limited reported a robust FY25 with a 5% revenue increase to A$408.1 million and a 105% surge in underlying EBITDA, driven by strong growth in Women’s Health and strategic acquisitions in Dermatology.
Ada Torres
Ada Torres
29 Aug 2025
Mayne Pharma reported a robust 5% revenue increase to $408.1 million and more than doubled its underlying EBITDA to $47 million in FY25, driven by strong Women’s Health sales and strategic acquisitions in Dermatology.
Ada Torres
Ada Torres
29 Aug 2025
Mayne Pharma reported a 5% revenue increase to $408.1 million for FY25 but posted a net loss of $93.8 million, narrowing from the prior year. The company’s planned acquisition by Cosette Pharmaceuticals faces legal hurdles, delaying completion.
Ada Torres
Ada Torres
29 Aug 2025
Adriatic Metals Plc shares have been suspended from the ASX to facilitate its proposed acquisition by Dundee Precious Metals Inc. under a UK scheme of arrangement.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Mad Paws Holdings reported a $12.27 million loss for FY25, deepening from last year, as it divests its Pet Chemist business and agrees to a $62 million acquisition by Rover Group.
Sophie Babbage
Sophie Babbage
28 Aug 2025